InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,282.01
(
0.30%
)
Post# of 24568
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade_zecco

Send PM Follow Ignore
Followers 54
Posts 4385
Boards Moderated 0
Alias Born 01/06/2010

Trade_zecco

Re: None

Monday, 10/11/2010 9:28:01 AM

Monday, October 11, 2010 9:28:01 AM

Post# of 24568
ALTH ($4.57) Announces Presentation of Favorable Survival Data from Randomized Phase 2b Study of FOLOTYN(R) in Patients with Advanced Non-Small Cell Lung Cancer

http://www.marketwatch.com/story/allos-therapeutics-announces-presentation-of-favorable-survival-data-from-randomized-phase-2b-study-of-folotynr-in-patients-with-advanced-non-small-cell-lung-cancer-2010-10-11?reflink=MW_news_stmp

Check out Daily Alert board for Next 10 Bagger:

http://investorshub.advfn.com/boards/board.aspx?board_id=15004

Check out Expert board here for Great picks:

http://investorshub.advfn.com/boards/board.aspx?board_id=16841

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up